This Business Strategy Presentation from Mitsui Chemicals, dated December 17, 2025, is a set of three business-sector strategy talks given by division presidents. It opens with a title slide listing the three sectors: Life & Healthcare Solutions, Mobility Solutions and ICT Solutions. Each sector follows the same sequence: a presenter introduction, a summary slide tying strategy to FY28 and FY30 targets, then detailed sections on sub-businesses. The Life & Healthcare section covers vision care, agrochemicals, oral care and testing/diagnosis. The Mobility section covers elastomers, composite materials and solutions and new business. The ICT section covers semiconductor and assembly, imaging, converting and EUV pellicles. The deck closes with a slide stating a vision to be a global solutions company and a standard disclaimer on forward-looking statements. Slides worth studying include the FY19 to FY30 strategy timeline on slide 3, which combines a bar chart with an annotated history of investments, and the Kulzer restructuring waterfall on slide 9, which pairs a bubble chart of ROIC against invested capital.
Slides worth studying



Questions about this deck
How many slides does the Mitsui Chemicals Business Strategy Presentation dated December 17, 2025 have?
The deck has 37 pages in total. Slide 1 is the title slide, and it lists the three sector businesses: Life & Healthcare Solutions, Mobility Solutions and ICT Solutions.
What does the Mitsui Chemicals deck say about the global market growth for vision care lenses?
Slide 4 gives the global market CAGR for 2024 to 2028 as 3% for ophthalmic lenses and 6% for high-refractive-index lenses. It lists MCI Vision Care at 6%+α, including peripheral domains.
What is the FY30 target for the Mobility Solutions business at Mitsui Chemicals?
Slide 17 shows the FY30 Target as 93B yen with an ROIC of 15%. Slide 19 also shows the FY30 Target at 93 in its operating income and EBITDA chart.
What does the Mitsui Chemicals deck say about the growth of the genetic testing sector?
Slide 12 states that the genetic testing sector has a CAGR of 8%, while the overall testing and diagnosis market has a CAGR of 5% for FY19 to FY25. It also notes that growth is being driven by a rise in infectious disease and personalized cancer treatments.
Details
- Company: Mitsui Chemicals, Inc.
- Year: 2025
- Type: Strategy presentation
- Industry: Chemicals
- Pages: 37
More from Mitsui Chemicals
All Mitsui Chemicals decks in the library
Review score: 7 out of 10, Effective
Presentation quality, judged with the SlideDeck Co review heuristic. Ask, evidence and idea merit are not rated here.
The deck has a clear route: three sector talks, each with the same sequence of presenter slide, summary slide, then sub-business pages. Every content page has a numbered section badge, a banded takeaway headline and a sector color (rose, blue-teal, gold), so a reader can find their place. Many pages are very dense with small text, as on slides 4, 5, 25 and 29, and several have rough craft: the untranslated Japanese label and the ROIC row colliding with the footer on slide 3, and low-contrast white-on-pink banner headlines on slides 3 and 9. The density suits a circulated investor document better than a spoken presentation, and the consistent frame and the strongest pages (slides 9 and 24) keep it competent and usable, with consequential weaknesses.
Worth keeping: Keep the repeated page frame with its numbered badge, banded takeaway headline and sector color, and the clear single-idea layouts of slide 9 (reform table beside the ROIC bubble path) and slide 24 (before-and-after battery pack with photos).
Most useful repair: Fix the legibility and fit defects: raise the contrast of the pale-pink banner headlines on slides 3 and 9, translate the Japanese label on slide 3, and move the ROIC row on slide 3 off the footer.
What would change the score: Split the densest pages (slides 4, 5, 25, 29, 30) into a lead message with one visual each, and replace the empty divider pages 15, 16, 18 and 20 and the sparse closing page 36 with an agenda that carries a takeaway.
Confidence medium. 37 of 37 pages inspected on contact sheets, 4 at readable size. Reviewed 2026-11-08. Model-assisted review (claude-sonnet-5-5).
Full text of the slides (37 slides)
Every slide's words and a description of its charts and images, so the deck can be searched and rebuilt. Also available as Markdown.
Slide 1
Mitsui Chemicals / December 17, 2025 / Business Strategy Presentation / ● Life & Healthcare Solutions Business / ● Mobility Solutions Business / ● ICT Solutions Business / Copyright © 2025 Mitsui Chemicals, Inc.
Visuals: Mitsui Chemicals logo: a stylised blue swoosh/arc mark in gradient from dark navy-blue (#1E4FA0) to bright cyan-blue (#1A9AE0) at its left, followed by the grey wordmark 'Mitsui Chemicals' in a bold condensed sans-serif (dark grey #555555). Right side: a large pale blue chevron (light blue #CCE0FA) filling the area from top to bottom and right of a diagonal edge, with its point at about the vertical middle pointing left into the white field; the chevron has no outline and no shadow and is a flat fill. No photographs, charts or other graphics.
Slide 2
0→1 MAKE IT HAPPEN
Business Strategy Presentation
Life & Healthcare Solutions
Mitsui Chemicals
林田 博巳
HAYASHIDA Hiromi
Managing Executive Officer,
Business Sector President,
Life & Healthcare Solutions Business Sector
December 17, 2025
Copyright © 2025 Mitsui Chemicals, Inc.
Visuals: Illustration: a large solid blue chevron (arrow shape) occupying the right side of the slide, from the top edge at about 58% x diagonally down to a point at about 90% x, 50% y, and back to the bottom edge at about 58% x. Flat fill, no gradient, no shadow, full-bleed to top and bottom edges. Logo 1: '0→1 MAKE IT HAPPEN' wordmark, grey bold condensed sans letters with a blue right-pointing arrow between '0' and '1'. Logo 2: Mitsui Chemicals corporate logo, a stylised blue swoosh made of three curved bands in dark-to-light blue, with 'Mitsui Chemicals' in grey sans-serif beside it. Vertical thin grey divider line between the logo and the presenter name block.
Slide 3
1
Pursuing Business Portfolio Transformation
Life & Healthcare Solutions
Dec. 17, 2025
Providing solutions that contribute to life, health
and comfortable lifestyles as our first pillar of earnings
Strategy to date
Strengthen vision care, agrochemicals
and oral care
Actively invest in wellness solutions
and medical solutions to create new
products and businesses
Environmental changes & business situation
Solid growth for vision care and
agrochemical products
Pursuing the restructuring of oral care
Progress toward new businesses and
M&A behind schedule
Strategy for achieving our FY28 targets
Pursue steady growth for vision care and
agrochemical products
Actively invest to turn medical solutions* into
a new pillar of earnings
*Oral care/orthopedics/testing & diagnosis
Seek proactive global expansion, including
through M&A
主な投資・施策
Production capacity increase for
high-refractive-index lens materials
(Vision care)
Acquisition of COTEC
(coating materials)
Acquisition of Coburn (ophthalmic
lens processing equipment)
Life care
(Agrochemicals)
Launch of three growth
driver products across
multiple markets
Acquisition of Meiji
Seika Pharma’s
agrochemicals business
Wellness
(Oral Care)
(Orthopedics)
Medical
Business and capital
partnership strengthened
with SHOFU (oral care)
Business and capital
partnership formed with
Japan MDM (orthopedics)
Business and capital partnership
formed with DNA Chip Research
(testing & diagnosis)
DNA Chip Research acquired
as a wholly owned subsidiary
(testing & diagnosis)
+31.5B
yen
14.8
23.1
24.9
29.2
30.0
34.1
35.5
67.0
86.0
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Outlook
FY28
Target
FY30
Target
(ROIC)
(5%)
(9%)
(8%)
(7%)
(6%)
(7%)
(10%)
(12%)
Copyright © 2025 Mitsui Chemicals, Inc.
Visuals: Bar chart (column chart) titled 主な投資・施策 with ROIC values beneath each bar. Eight bars at left and right groups separated by a gap: FY19 14.8 (ROIC 5%), FY20 23.1 (9%), FY21 24.9 (8%), FY22 29.2 (7%), FY23 30.0 (6%), FY24 34.1 (7%), FY25 Outlook 35.5 (no ROIC printed), FY28 Target 67.0 (10%), FY30 Target 86.0 (12%). Values are printed inside the top of each bar in white bold. Bar fill #DCB1B1 (dusty rose); the FY25 Outlook bar is the same colour. No printed axis, units or ranges; the bar values are the only scale. A translucent pale pink arrow (#E3A7AB at 42% opacity) rises from behind the FY25 bar toward the FY28 bar, labelled +31.5B yen in grey. Row labels at left: Life care box in #C96969, Wellness box in #D79191, Medical box in #E9C2C2, each with white bold text. Two dashed grey separator lines run horizontally across the chart. Logo: Mitsui Chemicals wing mark in blue and grey with the wordmark in dark grey. Section icon: a white heart-and-person pictogram on a rose square. Tab graphic: a navy #0B2A7A chevron with the number 1 in white.
Slide 4
2
Lifecare Solutions : Vision Care
Dec. 17, 2025
Accelerating growth by expanding into peripheral domains with
high-refractive-index lens materials, as well as with the coating materials & equipment business
Driving the market throughout the value chain,
including in peripheral domains
Lens
manufacturers
Lens processing
laboratories
Retail &
distribution
Consumers
Lens
polymerization
Prescription
lens processing,
cleaning, coating
Lens
materials
Coating
materials
Processing
equipment
Global
No.1
Hard coat
Photochromic
Anti-fog
Hydrophobic
Anti-reflective
Coating equipment
Cutting equipment
Grinding equipment
Global market CAGR 24–28
Ophthalmic lenses 3%
High-refractive-index lenses 6%
MCI Vision Care 6%+α
(including peripheral domains)
Expanding efforts to capture growing demand for
high-refractive-index lens materials
Reinforcing marketing efforts amid rapid market growth
China
Surge in demand for high-
refractive-index, high-quality
materials
Working with medium- and large-scale
retailers to strengthen the MR brand
India
Progress in shift to plastic
Supporting the popularization
of high-refractive-index lenses
Americas
Growth in demand
for high-strength offerings
Marketing new brand:
MR-8™plus (high-strength offering)
Increasing production capacity in line with demand
(January 2024; next planned for 2028)
Further growing the coating materials & equipment business
● Fleshing out our lineup of functional coating materials
Continuous
M&A and tie-ups
Bolstering our technological development capabilities for new coating
materials through tie-up with flō Optics (July 2025)
Developing new products through combination of coating materials and
processing equipment
Also focusing on new sectors such as AR/VR as we pursue expansion in all
sorts of surface coating markets
● Bolstering capabilities across production, sales & technology
Leveraging Coburn sites to
advance into emerging markets
South America, India, Africa, etc.
Expansion of U.S. site under SDC (October 2026)
Consolidating sites to enhance both technical support and capabilities
for development in line with local area
Bolstering R&D capabilities for next-gen materials
M&A/tie-ups
Tie-up,
new tech
Expansion of
U.S. site
(Sales revenue)
FY08 FY20 FY22 FY24 FY26 FY28 FY30
Outlook
Processing
equipment
Functional
coating materials
SDC’s coating
materials
Copyright © 2025 Mitsui Chemicals, Inc.
Visuals: 1. Value chain diagram in the grey panel: five rounded pill boxes in a row (Lens manufacturers, Lens processing laboratories, Retail & distribution, Consumers) joined by a grey (#A6A6A6) band with arrowhead pointing to Consumers. Under the first two pills are captions Lens polymerization and Prescription lens processing, cleaning, coating. Below them are three pills (Lens materials in #BE6E6E, Coating materials and Processing equipment in #DCB1B1 with blue #1A76BF outlines) with pale rose upward block arrows above them. Captions list Hard coat, Photochromic, Anti-fog, Hydrophobic, Anti-reflective and Coating equipment, Cutting equipment, Grinding equipment. 2. CAGR table in a white rounded box with a rose (#BE6E6E) border: rows Ophthalmic lenses 3% (CAGR 24-28), High-refractive-index lenses 6%, a horizontal divider, then MCI Vision Care 6%+α (including peripheral domains). Values are printed. 3. Three country rows (China, India, Americas) each a white rounded rectangle with a rose outline and a rose tab on the left holding the label; text in each row is printed as shown. 4. Stacked column chart labelled (Sales revenue), no axis tick values printed. Categories FY08, FY20, FY22, FY24, FY26, FY28, FY30 on a horizontal baseline; FY08 is a single short light column, later columns are stacked with three series from bottom: SDC's coating materials (#F0DCDC), Functional coating materials (#DCB1B1), Processing equipment (#BE6E6E). Heights rise left to right; values are about, not printed. Columns about 3 percent wide. Grey Outlook band beneath FY28-FY30 labelled Outlook. No legend box; the three series names sit at right as text labels. 5. Logos: sdc (Surface Coating), fsi (Coating Technologies), lti (Coating Technologies), COTEC, COBURN TECHNOLOGIES, each small, above pale rose block arrows pointing down at the chart. 6. Blue (#1A76BF) thick diagonal arrow from lower-left at FY20 to upper-right beyond FY30. 7. Pink elbow connector: vertical line with dots from the bullet at the top of the right column down to M&A/tie-ups, and a second elbow from the sub-bullet down to Expansion of U.S. site with a pale rose down arrow. 8. Mitsui Chemicals logo at top right: blue swoosh with grey wordmark. 9. Icon at top left beside the title: rose square with white heart and person outline.
Slide 5
3
Lifecare Solutions : Vision Care
Mitsui Chemicals
Dec. 17, 2025
Accelerating growth by expanding into peripheral domains with
high-refractive-index lens materials, as well as with the coating materials & equipment business
Ophthalmic
lens value
chain
Lens
manu-
facturers
Lens
polymer-
ization
process
Optical
labs
Processing
Prescription
processing,
addition of
functionality,
etc.
Glasses
retailers
Consumers
MR™ business
◆ Developing and providing new materials and technologies
◆ Boosting production capacity in response to demand
◆ Pursuing sales growth in growth markets
Coatings &
equipment business
Adopting new tech
Tie-up
◆ Continuously pursuing M&A and tie-ups
◆ Bolstering coating materials and technology development
◆ Advancing into emerging markets and pursuing sales growth
Business-wide sales revenue
FY16 FY20 FY24 FY28 FY30
Outlook
Sales growth in growth markets and emerging markets
China
Surge in demand for high-refractive-index, high-quality lenses
Strengthen the MR™ brand
Americas
Growth in demand for high-strength offerings
Marketing new brand: MR-8™plus
Expansion of U.S. site under SDC(2026)
Improving R&D, production and other capabilities
India
Progress in shift to plastic lenses
Supporting the popularization of high-refractive-index lenses
Utilizing COBURN regional sites to roll out technical support in the coating materials & equipment business (South America, India, Africa)
Providing value throughout the value chain, including in peripheral domains
Pursuing market expansion and sales growth worldwide
Copyright © 2025 Mitsui Chemicals, Inc.
Visuals: Vertical chevron value chain on the left in dusty rose tones, with stacked stages: Lens manufacturers, Lens polymerization process, Optical labs, Processing, Glasses retailers, Consumers. A dashed rounded-rectangle panel (rose dashes) encloses the MR business and coatings sections. Logos: MR by Mitsui Chemicals (top of panel); sdc, fsi, lti, COTEC, COBURN TECHNOLOGIES (in a row below Coatings & equipment business); James Robinson (Specialty Ingredients) boxed under Adopting new tech; flo logo boxed under Tie-up. Bar chart: vertical bars, rose-to-pale gradient, no printed values, labelled FY16, FY20, FY24, FY28, FY30 on a horizontal axis; y-axis titled Business-wide sales revenue with no units or range printed; about heights relative to each other: FY16 about 25%, FY20 about 35%, FY24 about 55%, FY28 about 80%, FY30 about 100% of the plot height; FY28 and FY30 bars are the outlook period, marked by a translucent white Outlook label box at the bottom-right of the plot. Map: grey line-art world map on white with no fill, with rose tab callouts China, India and Americas and two rose curved arrows, one pointing down-left near Africa and one pointing down-right near South America. Mitsui Chemicals logo top-right.
Slide 6
4 / Life Care: Vision Care / Mitsui Chemicals / Dec. 17, 2025 / Pursuing the development of new materials and technology to achieve continuous business growth / High strength / Photo- / chromic / Eco-friendly / New technologies / & fields / for AR/VR & / others / MR™ / by Mitsui Chemicals / SDC Technologies / Addition of functions / Expansion of realms / ◆ New high-strength brand: Expanding sales of MR-8™plus / • Impact-resistant lenses have a high market share in the U.S. / • Ensuring the brand offers adequate strength as an impact-resistant lens, while also seeking to balance this with optical properties / ◆ Photochromic materials and technologies / • Acquiring photochromic dye technology from James Robinson Speciality Ingredients, providing high-quality, high-performance photochromic systems that combine dyes with coating materials and processing equipment / ◆ Eco-friendly materials and technologies: DoGreen™ initiative / • Expanding sales of plant-derived brands (MR-160DG™, MR-174™ & others) / • Efforts to develop & commercialize technology for more efficient lens manufacturing processes / • Pursuing the chemical recycling of MR™ lens materials based on effective use of lens swarf and waste lenses / Raw materials / Disposal / Lenses / Carbon-neutral by 2050 / Support for developing sustainable eyewear products / Substantial waste reduction / Production / Product / Processing / ◆ New technologies and materials & technologies for new fields: AR/VR & others / • Tapping into digital technology to enhance development of next-gen coating materials and technology through our tie-up with flō Optics / • Developing hard coating materials offering high clarity and abrasion resistance for AR/VR applications / • Pursuing the development of high-performance materials for other fields, including automotive and electronic device applications / Copyright © 2025 Mitsui Chemicals, Inc.
Visuals: Left: a 2-axis matrix. A vertical axis arrow labelled Addition of functions (rotated, pinkish #BE6E6E) and a horizontal axis arrow labelled Expansion of realms, both drawn as thick #BE6E6E lines with solid triangular arrowheads. A soft pink-to-white gradient panel fills the matrix area, fading to white toward the lower-left and right edge. Four semi-transparent (opacity 0.70) #BE6E6E rhombus shapes: High strength (upper-left), Photo-chromic (upper-middle), Eco-friendly (centre), New technologies & fields for AR/VR & others (lower-right), each carrying white bold sans-serif labels. Thin #BE6E6E connector lines run from High strength and Photo-chromic to the right-hand headings, from Eco-friendly horizontally to its heading, and from New technologies down-right to the AR/VR heading. Logos: the MR™ mark with by Mitsui Chemicals beneath it in blue, and the SDC Technologies logo in blue with grey Technologies below. Right-hand middle: a DoGreen™ green handwritten-style logo with a green underline stroke sits in the Eco-friendly heading line. Lower-right: a flat cycle diagram of rounded navy #0B2E8A pills with white bold labels: Raw materials (top-left), Disposal (top-middle), Lenses (top-right), Production (bottom-left), Product (bottom-middle), Processing (bottom-right). Grey #A6A6A6 thick bars form a rectangular loop with a grey arrow pointing left from Disposal toward Raw materials. The inner rectangle is pale sage #CFD7A9 at about 60% opacity with a darker sage #CDD4A4 band in the middle, holding grey labels Carbon-neutral by 2050, Support for developing sustainable eyewear products and Substantial waste reduction. Top-right of the slide: Mitsui Chemicals logo with a blue swoosh and dark grey wordmark.
Slide 7
5 / Wellness Solutions :Agrochemicals / Dec. 17, 2025 / Maximizing value of active ingredients positioned / as growth drivers and accelerating their global rollouts / Doubling profit, with a / focus on growth drivers / CAGR 24–28 / Global market 2% / MCLS 6% / Growth drivers 7% / (Gross profit) / Four growth / driver ingredients: / 60% / FY19 / FY24 / FY28 / FY30 / Outlook / Dinotefuran, TENEBENAL™, / Flupyrimin, Glufosinate-P / Considering production / increases in line with demand / Accelerating rollouts to additional regional markets and applications / with a registration drive to maximize value of active ingredients / Registered countries for crop solutions / FY19 / FY20 / FY21 / FY22 / FY24 / Dinotefuran / Brazil / TENEBENAL™ / Japan, South Korea / China, Philippines, Indonesia / India / Vietnam, Thailand / Flupyrimin / Japan / India / Glufosinate-P / Grew domestic sales & bolstered overseas rollout / Registrations for TENEBENAL™ / vs. December 2024 / Crop solutions / Life solutions / Registered / 6➡8 / 22➡23 / Applied / 7➡5 / 1➡1 / Bolstering development of formulations and mixtures for each active ingredient / in line with the needs of various countries, regions and target markets / Breaking down markets by region, crop and pest to better analyze needs / Developing formulations and compounds able to differentiate themselves in target markets / Developing future growth drivers for beyond 2030 / Fleshing out our pipeline with both chemical and biological crop protection products / Actively conducting M&A both in Japan and abroad in pursuit of further business / expansion / Copyright © 2025 Mitsui Chemicals, Inc.
Visuals: 1) Column chart inside left rounded panel: stacked bars, two-tone (dark #BE6E6E bottom segment, light #DCB1B1 top segment) for FY19, FY24, FY28, FY30 on x-axis labelled Outlook (grey bar beneath FY28-FY30); no numeric axis labels; y-axis label '(Gross profit)'; bars increase left to right, FY30 bar has a light-pink to dark-pink gradient fill; values not printed (heights about: FY19 small, FY24 about 2x FY19, FY28 about 3x, FY30 tallest). Blue arrow (#1A76BF) rises diagonally from lower-left at FY19 to upper-right above FY30. 2) CAGR box: outlined rounded rectangle with title CAGR 24–28 and rows Global market 2%, MCLS 6%, Growth drivers 7% (7 in red). 3) Table 'Registered countries for crop solutions' with column headers FY19, FY20, FY21, FY22, (unlabelled blank column), FY24 and rows: Dinotefuran (Brazil in FY19), TENEBENAL™ (Japan, South Korea in FY20; China, Philippines, Indonesia in FY21; India in FY22; Vietnam, Thailand in FY24), Flupyrimin (Japan in FY19; India in FY22), Glufosinate-P (merged cell across FY20-FY24: Grew domestic sales & bolstered overseas rollout). 4) Small table 'Registrations for TENEBENAL™' with columns vs. December 2024, Crop solutions, Life solutions; rows Registered (6➡8 crop, 22➡23 life) and Applied (7➡5 crop, 1➡1 life); the 8 and 23 are red bold; a red dashed rectangle outlines the 6➡8 cell; a red dashed arrow with a left-pointing red arrowhead runs from the Registered row toward the Vietnam, Thailand cell. Grey arrow glyphs (➡) sit between values. 5) Logo: Mitsui Chemicals swoosh mark in blue with dark grey wordmark, upper right. 6) Section icon: white heart-and-person outline icon on pink tile at upper left. 7) Several small unlabelled images (64 and 70 pixel squares) with no legible content.
Slide 8
6 / Wellness Solutions :Agrochemicals / Mitsui Chemicals / Dec. 17, 2025 / Speeding up business growth through early achievement of positive effects from M&A / Agrochemical business acquired from Meiji Seika Pharma seeing steady growth above the initial plan / • Following integration of the sites of both companies when the acquisition was completed in January 2022, integrated the / companies themselves and carried out a reorganization a year later / • Established the BSRC in April 2023 with the objective of strengthening biosolutions research based on infrastructure for / naturally derived drug discovery, to further develop Meiji Seika Pharma’s strengths. Also expanded open innovation / • Measures to achieve synergies are progressing according to plan. Sales synergies in particular have been achieved earlier than / planned, worth in excess of 1 billion yen of costs per year / *1 Biological Solutions Research Center / BSRC Shinkiba Satellite Lab / Growth in ZAXA Liquid*2 / Initial plan revised upward due to effective use of / MCI’s domestic sales resources / ⇒ Planning to increase the Group’s domestic production / capacity for preparations / ZAXA Liquid / (Volume: kL) / FY23 / FY24 / FY25 / FY28 / FY30 / Plan at acquisition / Results + Outlook / Leveraging infrastructure at the Kitakami Factory / (factory acquired from Meiji Seika Pharma) / Development of ability to serve as our second major active / ingredient plant after the Omuta Works / Launch of probenazole and flupyrimin production; / achievement of business continuity planning in procurement / ⇒ Investment in equipment to reduce production costs, and in / turn further boost competitiveness, is proceeding smoothly / Rolling out a wide range of products using probenazole / and flupyrimin active ingredients produced at the Kitakami Factory / *2 Glufosinate-p (preparation containing an active ingredient originally from Meiji Seika Pharma) / Copyright © 2025 Mitsui Chemicals, Inc.
Visuals: Bar chart (ZAXA Liquid, Volume in kL, no axis numbers printed): categories FY23, FY24, FY25, FY28, FY30 on the horizontal axis; no vertical axis scale or values are printed, so bar heights are approximate. Series 1 Plan at acquisition in light pink #F1B9B9 (about FY23 low, FY24 slightly higher, FY25 mid, FY28 mid-high, FY30 about 60 percent of results). Series 2 Results + Outlook in dark rose #BE6E6E (FY23 about 45 percent of max, FY24 about 55 percent, FY25 about 65 percent, FY28 about 85 percent, FY30 tallest, fading to a lighter top). A solid blue arrow #1A76BF rises from left of FY23 to above FY30 across the bars. Legend below the category labels: light pink square Plan at acquisition, dark rose square Results + Outlook. Photo of ZAXA Liquid herbicide bottles at right of the chart: a small bottle with red cap and a large two-litre jug with red cap and red and white label reading サンサ, label text 2.0 L, company name Mitsui Chemicals Crop & Life Solutions, on a white background with soft shadow. Photo of BSRC Shinkiba Satellite Lab: a rendered architectural perspective of a seven-storey building with a grey-brown and white facade of horizontal and vertical stripes, a rooftop sign, a leafy tree and a street at the base, shown in daylight, full view, boxed without border. Five product photos in a row inside a pink rounded box: pink-and-white bag reading オリゼメート リディア 箱粒剤; teal bag with blue label reading リディア 箱粒剤; orange bottle with label エミリ フロアブル; light blue bag reading リディア 箱粒剤 with a blue band; green-and-white bag with a rice plant illustration reading オリゼメート 粒剤. All product photos are on white backgrounds, unboxed, same height. Mitsui Chemicals logo: blue swoosh mark and dark grey wordmark at upper right. Header icon: a pink rounded tile with a white outline icon of a person inside a heart with an arrow. Small section chevron: blue #0A3A8C square with white 6 and grey chevron.
Slide 9
7
Medical Solutions : Oral Care
Dec. 17, 2025
Improving profitability and capital efficiency via structural reform at Kulzer
and a global, group-wide strengthening of partnerships
Becoming a global leader
with a strong presence
ROIC
FY28
FY27
FY26
FY25
FY24
Bubble size =
operating income
before special items
Invested capital
Achieve
>9%
Achieve
ROIC = WACC
Pursue prompt restructuring
and return to a growth trajectory
Strengthen business foundations in key
overseas regions, including through M&A
① Structural reform: Optimizing structure to boost global competitiveness
Reorganization of sales sites
India, Singapore
Implemented in FY24
Downsizing SG&A personnel
15% reduction
Get S&GA ratio on par with global competitors
Majority completed in FY25
Continuing with aim to reach target level
Consolidation of production sites
Consolidate production of artificial teeth:
China & Germany → Germany
Improve production efficiency
FY25
② Invested capital reduction: Improving structure and reducing surplus capital within the Group
Structural reform
Reduce invested capital via ① Structural reform
Reduction of surplus capital
Optimize distribution of capital between group companies around the world
Reduce cash conversion cycle at group companies
③ Growth strategy: Increasing sales through efficient solutions marketing and Group integration
Improvements to sales & marketing approaches
Incorporate DX-based customer trend analysis to improve our ability to offer and market solutions
FY24 onward
Sales growth through Group integration
Grow sales by leveraging mutual synergy between Kulzer and SUN MEDICAL’s products and markets
Ongoing
Launch of new product: ZEN CAD-4 Block (CAD/CAM-based crown material)
FY25
Monomers utilizing tech from the vision care sector
Development & production
Sales
Copyright © 2025 Mitsui Chemicals, Inc.
Visuals: Bubble chart (left) with title 'Becoming a global leader with a strong presence' in red above it. Axes: vertical axis labelled ROIC (grey), horizontal axis labelled Invested capital (grey); no numeric scale or units printed. Five pink bubbles in a descending diagonal from upper left to lower right, labelled FY28 (largest, about 6 percent by 11 percent of slide), FY27, FY26, FY25 and FY24 (smallest), with small grey arrows between consecutive bubbles pointing down-right. Bubble size legend text: 'Bubble size = operating income before special items'. Two dotted dark-pink horizontal lines cross the chart: the upper one at about 46 percent of slide height labelled 'Achieve >9%' in a red-outlined box, the lower one at about 54 percent labelled 'Achieve ROIC = WACC' in a red-outlined box. A dotted-outline empty circle at upper right of the chart with a thick dusky-rose arrow pointing up-right toward it. Below the chart, a pink downward triangle pointing to the red conclusion text. Logo row in table: Mitsui Chemicals logo (blue swoosh with dark text), a multiplication sign, SUN MEDICAL logo (blue diamond mark with blue text), a multiplication sign, Kulzer logo (green circle icon with black KULZER wordmark and small text MITSUI CHEMICALS GROUP) on a white strip, with captions beneath: 'Monomers utilizing tech from the vision care sector' under the Mitsui logo, 'Development & production' under SUN MEDICAL, 'Sales' under Kulzer. Product photograph at right of the Sales row: a black and white product box labelled ZEN CAD-4 with four pale beige CAD/CAM crown blocks in front, shown at a three-quarter angle on a light grey background, full colour pale tones with dark box, no crop. Heart-in-hands icon in pink square at top left of title and a blue chevron with white '7'.
Slide 10
8
Medical Solutions: Oral Care
Mitsui Chemicals
Dec. 17, 2025
Pursuing structural reform through focus on EMEA and U.S. growth markets,
along with the lean management introduced in 2018
Sale of SUN MEDICAL’s new
products by Kulzer in the U.S.
Concentration of artificial
teeth production in Europe
Reducing S&GA ratio to a level below
global competitors
Global competitors’
S&GA ratio
Scope for a 15% reduction
in S&GA personnel
FY24 FY25 FY26 FY27 FY28
Withdrawing from
inefficient areas
Opening of Saudi Arabian branch to
bolster business in the Middle East & Africa
Efficiency improvements in growth markets
✓ Reducing operational flows by appointing a
new CEO to implement agile practices
✓ Expediting decision-making by stationing the
Business Sector Vice President at the U.S. site
✓ Improving productivity by consolidating sites
(branches and plants)
✓ Increasing the efficiency of sales through
DX-powered customer analysis
Copyright © 2025 Mitsui Chemicals, Inc.
Visuals: Full-bleed pale rose-red world map (illustration) covering the slide, with a soft blue radial glow ellipse centred over Africa and the Atlantic. Blue semi-transparent curved arrows: one from the Sale of SUN MEDICAL box down to the U.S. flag; one from the Asia area curving left to the Europe callout; one from Asia to the Europe/Middle East area; one from the Middle East box up to the Europe area. A US flag (about 5.5% wide) sits below the first callout. An EU flag and a German flag (black, red, gold horizontal tricolour) sit side by side under the Europe callout. A bar chart titled Reducing S&GA ratio to a level below global competitors: five rose bars (#BE6E6E) labelled FY24, FY25, FY26, FY27, FY28 on the x-axis, bars descending left to right; values are not printed, so heights are about: FY24 about 85% of the chart height, FY25 about 75%, FY26 about 65%, FY27 about 55%, FY28 about 40%. A horizontal dashed dark grey line (#595959) marks Global competitors’ S&GA ratio across the chart at about 67% height. The chart has a black baseline. A rose-outlined boxed label Scope for a 15% reduction in S&GA personnel overlies the lower bars. A dashed dark navy ellipse encloses the Southeast Asia area with the label Withdrawing from inefficient areas. Four white checkmarks in the bullet list (Wingdings ✓). Logo: Mitsui Chemicals wave mark in blue and grey wordmark at top right.
Slide 11
9
Medical Solutions: Oral Care
Dec. 17, 2025
Leveraging the Group’s comprehensive strengths to solve social challenges
Social challenge*
Helping to ensure a
stable supply of complete dentures
2025 • Japan’s first 3D-printed complete dentures
materials covered by national health insurance
2024 • Launched material for
dentures & temporary crowns
Artificial teeth
Denture bases
2023 • Launched high toughness
denture base material
Mouthguards
2022 • Launched materials for implant surgical
guides and impression trays
2021 • Launched material for mouthguards
2020 • Launched Japan’s first 3D-printed denture material,
and materials for dental casting and models
2019 • Launched material for dental models
2018 • Launched material for dental casting
2017 • Received U.S. FDA approval for the
world’s first 3D printed denture materials
Metal casting molds
Efforts to solve social challenges
using 3D printing
Reduces complete denture
production time
Delivers stable,
uniform production
*A shortage of dental technicians due to
the aging of skilled technicians involved in
making complete dentures by hand,
coupled with a lack of young technicians
Uniting Mitsui Chemicals’ expertise in chemicals and 3D printing with Kulzer’s ability to provide solutions
for the dental market and SUN MEDICAL’s capabilities in medical device production technology
Copyright © 2025 Mitsui Chemicals, Inc.
Visuals: A rising pale-pink translucent diagonal arrow (#EFADAD at about 40% opacity) runs from bottom left (near 2017) to upper right (near the 2025 entry), with its head at about x 62%, y 18%. Photographs: (1) a complete denture photograph (pink gums, yellow-white teeth) boxed, top centre, at about x 46.5% y 17.2% w 11.2% h 15.5%; (2) a grey 3D-printed artificial teeth model with yellow front teeth and small holes, cut out, labelled 'Artificial teeth', at x 22.6% y 23% w 11.6% h 11.7%; (3) a pink denture base cutout labelled 'Denture bases', at x 11.8% y 31.6% w 10.6% h 11.1%; (4) mouthguards (blue upper, white lower) labelled 'Mouthguards', at x 0% y 37.9% w 13.3% h 23.8%; (5) red 3D-printed metal casting molds labelled 'Metal casting molds', at x 50.4% y 67.8% w 13.1% h 16.4%; (6) a white and orange 3D printer machine with a small blue screen, cut out inside the call-out box, at x 67.2% y 48% w 8.3% h 21%. Dotted red leader lines connect labels to products and the 2020 entry. Logos: Mitsui Chemicals logo (blue swoosh with grey wordmark) at top right, and a pink square icon with a person-in-heart symbol at top left. Shape details: two pale-pink rounded rectangles (#EFADAD at 20% opacity) behind the call-out text lines at x 75.1% y 52.1% and x 75.1% y 60.5%, each 23.1% by 7%.
Slide 12
10
Medical Solutions:
Acquisition of DNA Chip Research as a Wholly-Owned Subsidiary
Acquiring business foundations in the genetic testing sector
to speed up growth in the testing and diagnosis business
Dec. 17, 2025
Overall testing &
diagnosis market:
CAGR 5% FY19~25
Genetic testing sector:
CAGR 8%
Growing rapidly amid a rise in infectious disease and personalized cancer treatments
High hopes for new solutions to meet increasingly sophisticated medical needs
Basic strategy:
Step 1
FY22
Develop unique technologies
Find partners
Step 2
FY25
Acquire business foundations
Step 3
FY28~
Flesh out revolutionary
testing and diagnosis offerings
Grow business worldwide
DNA Chip Research acquired as a
wholly-owned subsidiary
Leveraging both companies’ strengths to generate synergy
DNA Chip Research Inc.
Highly sensitive genetic analysis tech
Capabilities in development,
pharmaceuticals affairs ,
testing operations, sales and more
×
Mitsui Chemicals
Biotech infrastructure,
management resources, global
network, CVC capabilities
Expand & grow the range of
unique testing and diagnosis
offerings and create new business
Advance into global markets
e.g. the U.S.
Source technology through
partnerships with startups
Develop DNA Chip Research’s existing business
DNA Chip Research Inc.
Testing & diagnosis business sales revenue
Bolster sales and marketing for the Lung
Cancer Compact Panel™*, DNA Chip
Research’s mainstay product
Flesh out range of offerings for diseases
beyond lung cancer
Jointly developed items
Development started on one in FY2024
and one in FY2025
*Lung Cancer Compact Panel™ Dx Multiplex Companion Diagnostic System,
DNA Chip Research’s name for a genetic testing service to help select treatments for cancer
and other diseases for individual patients
Copyright © 2025 Mitsui Chemicals, Inc.
Visuals: One chart: a pale pink upward trend arrow over three vertical bars labelled on the x-axis FY23, FY24 and FY30, titled 'Testing & diagnosis business sales revenue' in grey, with no printed axis units, ranges or values. Bars are about 15% (FY23), about 55% (FY24) and about 100% (FY30) of the plot height, filled dusky rose #BE6E6E with the FY30 bar shaded with a white-to-pink gradient at its top; no legend; no highlighted points. Logos: DNA Chip Research Inc. (cyan and black stylised DNA symbol with 'DNA Chip Research Inc.' wordmark in dark grey) appears twice, at the left column and at the top of the callout; Mitsui Chemicals (blue swoosh with grey wordmark) appears at top-right and bottom-left. A red-rose multiplication sign × sits between the two company blocks. A pale pink block arrow points right from the left column to the centre column. Three white rounded step boxes contain text; a thick rose outline surrounds Step 2. Two thin light-grey outlined hollow arrows connect the step boxes. A pale pink downward triangular arrow points from the band to the red caption. Small unlabelled raster images sit near the callout corner and near the bottom-right footnote.
Slide 13
Medical Solutions: DNA Chip Research
11
Dec. 17, 2025
• Acquired DNA Chip Research as a wholly owned subsidiary in June 2025. Invested human resources, including as / president, in pursuit of post-merger integration
• Mainstay business the Lung Cancer Compact Panel™* offers excellent detection sensitivity and can also be used for / cytological specimens
➡ Helps to ensure prompt administration of appropriate drugs by enabling testing of patients who had been unable to undergo / multiplex companion diagnostics
• Leveraging our business foundations to expand the business by rolling it out overseas. Currently also devoting efforts to / developing new diagnostic content for diseases other than lung cancer
Lung Cancer Compact Panel™
Growth of the Lung Cancer Compact Panel business
Multiplex companion / diagnostics
Lung Cancer / Compact Panel , etc.
EGFR
ALK
KRAS
BRAF
ROS1
RET
MET
⚫ A type of companion diagnostics / that uses multiplex gene testing / to simultaneously measure gene / mutations crucial to the selection / of drugs to treat lung cancer
⚫ Investigating multiple genes at / the same time allows the most / appropriate drug to be provided / to each individual patient
Features
High detection sensitivity
Also compatible with / cytological specimens
Detects key genes at the same time
Can add detection of new / driver gene mutations
First lung cancer gene panel / produced in Japan
⚫ Positioned to grow to become / a major diagnostic option in / Japan, tapping into the strengths / offered by its design tailored to / the genetic characteristics of / Japanese and other Asian people, / along with high sensitivity that / permits high-precision analysis / even when using only very small / samples / ⚫ Delivers reliable diagnoses while / minimizing the risk and burden / for the patient
⚫ Considering the inclusion of / additional genes and drugs / ⚫ Bolstering sales and marketing / activities / ⚫ Overseas rollout leveraging / our business foundations
Number of tests / on the rise
FY2023
FY2024
FY2025
FY2028
Further increases in the / number of tests, leading to / business growth in Japan / and overseas
*Lung Cancer Compact Panel™ Dx Multiplex Companion Diagnostic System
Copyright © 2025 Mitsui Chemicals, Inc.
Visuals: 1) Pictogram diagram at upper left: about 30 small multicoloured standing person figures in a row (blue, green, yellow, purple, orange, red, cyan repeated) above a light blue box reading Multiplex companion diagnostics and a pink box reading Lung Cancer Compact Panel™, etc. with a pink arrow pointing from the pink box to the blue box. Below, black connector lines drop from the blue box to seven columns labelled EGFR (green), ALK (yellow), KRAS (cyan), BRAF (purple), ROS1 (blue), RET (orange), MET (red). Each column shows coloured person figures (EGFR about 4 green, ALK 2 yellow, KRAS 2 cyan, BRAF 1 purple, ROS1 1 blue, RET 1 orange, MET 1 red), a down arrow in the same colour, and an outlined pill bottle in the same colour. 2) Bar chart titled with the header Growth of the Lung Cancer Compact Panel business (no chart title in plot). Vertical bar chart, category axis FY2023, FY2024, FY2025, FY2028 with an axis break marks between FY2025 and FY2028, so FY2028 is not to scale. Value axis has no visible numbers or units (value labels are hidden under a white box). Estimated bar heights (about, no values printed): FY2023 about 1,900; FY2024 about 5,600; FY2025 about 8,400; FY2028 about 13,000. No legend; no highlighted points. A thick rose trend arrow (#BE6E6E) rises from the top of the FY2023 bar to an arrowhead above FY2028 and is labelled Number of tests on the rise in bold red. 3) Five rounded feature boxes (light pink fill, navy outline) stacked at left. 4) Rose chevron arrows: one pointing right between Features list and the description column, one pointing right between the bullets and the Further statement. 5) Mitsui Chemicals logo (teal-blue swoosh and grey wordmark) top right. 6) Icon at top left: white heart-and-person outline with arrow on dusty pink square. 7) Navy badge with white page number 11 and grey chevron.
Slide 14
0→1 MAKE IT HAPPEN / Business Strategy Presentation / Mobility Solutions / Mitsui Chemicals / 小守谷 敦 / KOMORIYA Atsushi / Managing Executive Officer, / Business Sector President, / Mobility Solutions Business Sector / December 17, 2025 / Copyright © 2025 Mitsui Chemicals, Inc.
Visuals: Illustration: a solid blue chevron/arrow shape (picture box 624 by 1650 px) at x 57.8%, y 0%, w 42.2%, h 100%. It is a flat arrow with its point at the left edge of the box near mid-height (about y 50%, x 57.8%), with the upper and lower edges running diagonally to the top and bottom edges of the slide, and the remaining area of the box filled solid blue to the right edge. It bleeds off the top, right and bottom edges of the slide. Dominant colour is a deep royal blue of about #00449A. No gradient, shadow or overlay. Logo 1: the 0→1 MAKE IT HAPPEN logo at x 4.4%, y 2.4%, w 25.4%, h 5.2%: bold condensed sans grey (#6D6E71) letters reading 0, a blue (#1A9AD6) right arrow, 1, then MAKE IT HAPPEN, on a white ground. Logo 2: the Mitsui Chemicals logo at x 9.9%, y 75.7%, w 22.2%, h 7.0%: a blue swoosh mark made of three curved bands (dark blue #0A4FA0 on the left curving to light blue #1E9BE0 at the top right) beside the grey (#5A5A5A) wordmark Mitsui Chemicals. Divider: a thin vertical dark grey (#404040) hairline, about 1 px wide, at x 34.5%, from y 70.8% to y 87.5%, separating the logo from the presenter block.
Slide 15
Contents/Agenda
Mitsui Chemicals
Dec. 17, 2025
Mobility Solutions Business Strategy for
VISION 2030
Mobility Solutions Business Earnings and
Targets
Mobility Solutions Business Strategy
Elastomers
Composite materials
Solutions & new business
Copyright © 2025 Mitsui Chemicals, Inc.
Visuals: Mitsui Chemicals logo at top right: a stylised blue swoosh/wave mark in blue (#1E6FB8 to #0B3C8C gradient) followed by the grey wordmark 'Mitsui Chemicals'. Large white hexagonal chevron panel on the right side with a soft grey shadow along its left angled edge; the panel fill is a white-to-light grey-blue gradient (#FFFFFF at upper left to about #CFD9E3 at lower right). Three solid navy right-pointing triangular bullets (about #072884) beside the first-level items. No photographs, charts or diagrams.
Slide 16
Mobility Solutions Business Strategy / for VISION 2030 / Dec. 17, 2025 / Copyright © 2025 Mitsui Chemicals, Inc.
Visuals: Two solid dark-blue chevron marks (double right-pointing chevrons, like a fast-forward symbol) sit to the left of the title. A pale grey, blurred-edge chevron shading runs down the right side of the slide, pointing right, behind the title. It is a soft shadow-like band, not a photograph. The Mitsui Chemicals logo at top right is a blue and grey swoosh mark beside the grey wordmark 'Mitsui Chemicals'.
Slide 17
Mobility Solutions Business Strategy for VISION 2030
1
Mitsui Chemicals
Dec. 17, 2025
Ideal vision
Providing unique materials, features and services to solve
social challenges and let us achieve sustainable business growth
Contribute to solve social
challenges through materials
Materials
business
Elastomers
Composite
materials
Pursuing portfolio
transformation
through a focus on growth
markets and differentiation
Offering solutions that
combine materials with services
Solutions
business
Solutions &
new business
• Expectations for new
solutions, with the mobility
field facing a once-in-a-
century change
• Aiming to create new focal
areas in addition to our
materials business
93B yen
72B yen
53B yen
FY25 Outlook
FY28 Target
FY30 Target
ROIC 10% 12% 15%
Pursuing business expansion through the three pillars of
elastomers, composite materials, and solutions & new business
Copyright © 2025 Mitsui Chemicals, Inc.
Visuals: Bar chart, untitled, with three vertical bars rising from a shared baseline at the bottom of the bars, drawn to scale (heights proportional to 53, 72 and 93). Bar 1 is labelled FY25 Outlook, value 53B yen, ROIC 10%. Bar 2 is labelled FY28 Target, value 72B yen, ROIC 12%. Bar 3 is labelled FY30 Target, value 93B yen, ROIC 15%. No y-axis, gridlines or legend are printed; the values are the printed labels. Bars carry a vertical gradient from pale blue at the top to dark teal at the bottom. A semi-transparent yellow (#FFD966 at 70 percent opacity) upward-pointing arrow overlays the bars, starting near the top of FY25 bar's lower left area and ending with its head above FY30 bar, highlighting the growth trend. Also a large right-pointing block arrow in blue-grey #689BB0 behind the middle column, its head at the right tip pointing toward the chart, with a soft horizontal gradient from transparent on the left fading into the arrow body. A small presenter icon in a teal square at top left (a person at a desk with speech-wave lines). A Mitsui Chemicals logo at top right: a blue swoosh mark with the wordmark. The 'Ideal vision' label is a grey-blue wordmark inside a white box at left of the band.
Slide 18
Dec. 17, 2025
Mobility Solutions Business
Earnings and Targets
Copyright © 2025 Mitsui Chemicals, Inc.
Visuals: Two solid dark blue double-chevron (chevron-arrow) shapes, filled #072884, placed side by side to the left of the title, each about 3.8% wide and 11.1% tall, with no outline. A large light grey, soft-edged chevron band runs down the right side of the slide, pointing left toward the centre, filling the right area with a faint grey gradient shadow. The Mitsui Chemicals logo sits at top right: a blue and light-blue swoosh emblem next to dark grey 'Mitsui Chemicals' wordmark.
Slide 19
2 / Mobility Solutions Business Earnings and Targets / Mitsui Chemicals / Dec. 17, 2025 / Driving further growth with efforts focused on the shift to growth markets and differentiation / (単位:億円) / ■ Operating income before special items / EBITDA / 93 / 72 / 53 / 58 / 55 / 49 / 33 / Volume / +6.0 / Elastomers(+) / Terms / of trade / (5.5) / TAFMER™/PP compounds(-) / Foreign exchange impact(-) / Costs, etc. / (2.6) / New plant(-) / Business / restructuring(+) / Return from / previous / investments / & Organic / growth / Increase in / fixed costs / (New / investments) / FY21 / Results / FY22 / Results / FY23 / Results / FY24 / Results / FY25 / Outlook / FY28 / Target / FY30 / Target / Copyright © 2025 Mitsui Chemicals, Inc.
Visuals: Combined waterfall and bar chart with EBITDA line, titled by the slide title, unit (単位:億円, hundreds of millions of yen; no axis is drawn and no axis range is printed). Bars with printed values: FY21 Results 33, FY22 Results 49, FY23 Results 58, FY24 Results 55, FY25 Outlook 53, FY28 Target 72, FY30 Target 93. Waterfall steps between FY24 and FY25: Volume +6.0 (orange bar, callout 'Elastomers(+)'), Terms of trade (5.5) (pink bar, callout 'TAFMER™/PP compounds(-)' and 'Foreign exchange impact(-)'), Costs, etc. (2.6) (pink bar, callout 'New plant(-)' and 'Business restructuring(+)'). Between FY25 and FY28: Return from previous investments and Organic growth (blue bar, about +19 units tall relative to the scale, no printed value) and Increase in fixed costs (New investments) (pink bar, no printed value). Series 1 is the light blue-grey and mid teal bars as listed. Series 2 is an EBITDA line in #689BB0 with round markers, drawn as a smooth curve through the FY21 to FY24 markers and marker dots at FY25 Outlook, FY28 Target area and FY30 region, with no printed EBITDA values. Legend at upper left: a teal square labelled Operating income before special items and a teal line with two circle ends labelled EBITDA. Highlighted points: FY25 Outlook value 53 printed in red #C00000, FY28 and FY30 values printed in navy #003399. No axis lines except a black horizontal baseline. Logo: Mitsui Chemicals wordmark with blue swoosh at upper right. Icon: a white presentation-and-signal pictogram on a teal tile at left of the title.
Slide 20
Mitsui Chemicals / Dec. 17, 2025 / Mobility Solutions Business Strategy / Copyright © 2025 Mitsui Chemicals, Inc.
Visuals: Two identical solid navy double chevrons (>>) pointing right, stacked side by side, placed to the left of the title at the title's vertical midline. A large soft-grey shadowed arrow panel fills the right side of the slide: a white chevron-shaped area whose point sits at about 82.6% width at mid-height, with a feathered light-grey shadow along its edges. The Mitsui Chemicals logo at top right: a blue swoosh icon followed by the grey wordmark 'Mitsui Chemicals'.
Slide 21
3 / Mobility Solutions Business Strategy / Dec. 17, 2025 / Combining seeds-driven market development / with the provision of solutions and needs-driven materials / Provision of materials / Elastomers / Composite materials / Solutions & new business / Social challenge / Identify social challenge; explore / themes for commercialization / Select theme; set and / verify hypothesis / Build business / model / Commer- / cialize / Future mobility / New / business / Ethylene / Propylene / Other / monomers / MCI / products / Procured / raw / materials / Develop- / ment / needs / Polymer design and / catalyst technologies / Polymerization / process technologies / New polymerization processes / Technologies / (formulation, mixing, compounds) / Local production for local / consumption setups in each region / Offering concepts / for modular components / Develop- / ment / needs / Functional / support / for / concept / develop- / ment / Collaboration / Utilization of other materials / Business partners / Collaboration / Seeking to bolster business by ensuring the three pillars leverage / the strengths linked by the value chain and collaborate organically / Copyright © 2025 Mitsui Chemicals, Inc.
Visuals: Diagram. Three large panels. (1) Elastomers panel, blue #2F5597: inside, two grey rounded boxes 'Ethylene Propylene' and 'Other monomers' joined by a navy plus sign, then a navy multiplication cross, then three stacked light-blue rounded bars 'Polymer design and catalyst technologies', 'Polymerization process technologies', and a dotted-outline pale-blue bar 'New polymerization processes'. (2) Composite materials panel, green #548235: grey boxes 'MCI products' and 'Procured raw materials' joined by a navy plus sign, a navy multiplication cross, then three stacked light-green bars 'Technologies (formulation, mixing, compounds)', 'Local production for local consumption setups in each region', 'Offering concepts for modular components'. (3) Solutions & new business panel, orange #C55A11: grey box 'Social challenge' above a navy down arrow feeding an inverted funnel of four tiers, shaded from pale peach to deep orange: 'Identify social challenge; explore themes for commercialization', 'Select theme; set and verify hypothesis', 'Build business model', 'Commer-cialize'. Two navy circular-arrow loop icons sit between funnel tiers. Below the funnel, a grey band holds an orange filled box 'Future mobility' and a dashed-orange outlined box 'New business'. Logos: ARRK in blue wordmark and KYOWA in red outlined wordmark, set over a pale blue-grey curved arc. Arrows: thick blue elbow connector from Elastomers top to the right panel top, green elbow connector from Composite top to the right panel top; three green left-pointing arrows between Elastomers and Composite labelled 'Development needs'; three orange left-pointing arrows between Composite and Solutions labelled 'Development needs'; one orange left-pointing arrow labelled 'Functional support for concept development'. Blue double-headed arrows (four each) with 'Collaboration' labels link the bottom boxes to the Composite and Solutions panels. Logo: Mitsui Chemicals swoosh mark in blue with dark grey wordmark, top right. Icon: white presentation/person icon on a steel-blue tile, top left, next to the navy chevron with number 3.
Slide 22
4 / Mobility Solutions Business Strategy / (1) Elastomers / Dec. 17, 2025 / Cultivating markets and pursuing differentiation by leveraging polymers with unique strengths / via the combination of raw materials, catalysts and production technologies / TAFMER™ / Alpha-olefin copolymer / MITSUI EPT™ / Ethylene-Propylene Terpolymer / LUCANT™ / Ethylene-alpha-olefin co- / oligomer / Business strategy / Continually launch / differentiated products / Supply raw materials for / composite materials / Develop new polymers / and establish / polymerization / technologies / China / Local / production / for local / consumption / Sharing / differentiation / technologies / Japan / - Mother plant / (R&D site and production of / differentiated products) / - Considering a next-generation / elastomer plant / Singapore / ‒ Global supply using our large-scale plant / ‒ Operation of new plant / TAFMER™ / MITSUI EPT™ / LUCANT™ / Achieving further growth and major advances as a front-runner / by continually bringing new products to market / Copyright © 2025 Mitsui Chemicals, Inc.
Visuals: Grey world map (raster, 1984 by 939 px) across the right two-thirds of the slide with curved light-blue arrows and translucent overlays. Left panel contains a 2x2 photo collage (about 537 by 338 px): top-left a car on a road with an electric-vehicle charging station and a digital overlay, top-right the rear seats and trunk of a white concept car with tan seats, bottom-left a battery-electric vehicle chassis with a battery pack, bottom-right white pouch packages with a recycling symbol. Five light-blue curved arrows: one from Japan arcing over Asia to Europe with its head pointing left, one from Japan arcing to North America with its head pointing right, one from Singapore to Africa with head pointing up-left, one from Singapore up to India with head pointing up, one from Singapore to South America with head pointing right. Pink translucent ellipse over China, yellow translucent elongated ellipse over Japan and Southeast Asia. Coloured dots: red (TAFMER), green (MITSUI EPT), yellow (LUCANT) — one green dot over China; one red, one green and one yellow dot at Japan; one red dot near Singapore. Legend at bottom right: red circle TAFMER™, green circle MITSUI EPT™, yellow circle LUCANT™.
Slides 23 to 37 continue in the full text file.
Download this deck
The hosted PDF of every library deck is free for readers of the SlideDeck Co newsletter. Join with your email and the viewer and download appear here.
Preparing a strategy presentation of your own? The SlideDeck Co Consulting Deck is a slide library with a statement of work and a worked client case.






